Rekombinanter Decorin Antikörper (AA 212-336)
Kurzübersicht für Rekombinanter Decorin Antikörper (AA 212-336) (ABIN7872208)
Target
Alle Decorin (DCN) Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 212-336
-
Verwendungszweck
- Recombinant Decorin Antibody / DCN
-
Aufreinigung
- Protein A/G affinity
-
Immunogen
- A recombinant human Decorin protein fragment (within amino acids 212-336) was used as the immunogen for the recombinant Decorin antibody.
-
Isotyp
- IgG, kappa
-
-
-
-
Applikationshinweise
- Optimal dilution of the recombinant Decorin antibody should be determined by the researcher.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the recombinant Decorin antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- Decorin (DCN)
-
Andere Bezeichnung
- Decorin
-
Hintergrund
- Decorin is a small leucine-rich proteoglycan (SLRP) family member that consists of a glycosaminoglycan chain-containing core protein. The core protein contains ten leucine rich repeats that contain sites for glycosylation, flanked by disulfide bond stabilizing loops. Decorin binds to Collagen Type I, II and IV in vivo and promotes the formation of fibers with variations in stability and solubility. The Decorin core protein binds to growth factors, intercellular matrix molecules, such as Fibronectin and Thrombospondin, and to the Decorin endocytosis receptor. Decorin binds to and inhibits TGFbeta and is a direct or indirect negative modulator of TGFbeta synthesis. Inhibition of Decorin core protein gene expression by the combination of IFN-gamma and TNFAlpha may contribute to cartilage destruction that is characteristic of inflammatory joint diseases. For immunostaining, pre-incubation with chondroitinase-SBC or testicular hyaluronidase may be required to expose the epitope.
-
UniProt
- P07585
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-